id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-1446-0003,FDA,FDA-2013-D-1446,"Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use;
Draft Guidance for Industry and Food and Drug Administration Staff;
Extension of Comment Period",Notice,Extension of Comment Period,2014-04-09T04:00:00Z,2014,4,2014-04-09T04:00:00Z,2014-05-08T03:59:59Z,2014-05-13T14:36:48Z,2014-07899,0,0,09000064816aba2d
FDA-2013-D-1446-0002,FDA,FDA-2013-D-1446,"Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use;
Draft Guidance for Industry and Food and Drug Administration Staff",Other,Guidance,2014-01-08T05:00:00Z,2014,1,2014-01-08T05:00:00Z,,2024-11-07T23:01:04Z,,1,0,09000064814f488e
FDA-2013-D-1446-0001,FDA,FDA-2013-D-1446,"Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use;
Draft Guidance for Industry and Food and Drug Administration Staff;
Availability",Notice,Notice of Availability,2014-01-07T05:00:00Z,2014,1,2014-01-07T05:00:00Z,2014-04-08T03:59:59Z,2014-04-08T01:02:00Z,2014-00022,0,0,09000064814f12af